Parexel mounts a share buyback; WuXi uses its Harvard ties;

> Parexel ($PRXL) is setting aside $200 million to buy back 2.3 million of its own shares in what CEO Josef von Rickenbach said is "an important step toward continuing to optimize the capital structure of the company." More

> WuXi PharmaTech's ($WX) Harvard ties helped it land a big genomics partnership in China. News